May 2012
MondayMorning;5/21/2012, Vol. 20 Issue 21, p1
The article discusses financial performance of Danvers, Massachusetts-based Abiomed Inc. It has been informed that the firm reported profit in the fiscal fourth quarter of 2011 due to increased sale of Impella devices. It has been informed that Abiomed reported earning of 2.6 million dollar or 6 cents per share in the first three months which ended on March 31, 2012.


Related Articles

  • Regeneron, Abiomed Hit High. Investor's Business Daily // Investors Business Daily;8/5/2015, pA01 

    3 The biotech's Q2 EPS rose 17% to $2.89, beating.

  • CORPORATE.  // MondayMorning;4/6/2009, Vol. 17 Issue 13, p2 

    The article offers news briefs related to the health care industry in the U.S. The earnings per share of Humana Inc., a provider of U.S. government-sponsored health plans, have more than doubled. Abbott Laboratories Inc.'s earnings have increased by 62% due to rising revenue from the drugs made...

  • Coventry exceeding expectations.  // Dow Theory Forecasts;10/6/2003, Vol. 59 Issue 40, p8 

    Focuses on the performance of managed health care programs provider Coventry Health Care Inc. as of October 6, 2003. Earnings per share of the company between the September 2002 and the June 2003 ; Profile of the company; Price-earning ratio of the company between the September 2002 and the...

  • Abiomed up on guidance hike. Investor's Business Daily // Investors Business Daily;2/4/2016, pA02 

    The article discusses financial performance of heart pump maker Abiomed in the third quarter as of February 2016, which reported a decline in its earnings per share, and growth in sales; and mentions that the company raised revenue guidance for the fiscal year 2016.

  • 3Q Earnings Scorecard.  // American Banker;10/11/2013, Vol. 178 Issue F340, p14 

    The article refers to a third-quarter 2013 corporate earnings scorecard and notes the earnings-per-share figures have been adjusted and might diverge from standard accounting (GAAP) figures.

  • MEDTRONIC INC. (Minneapolis MN).  // MondayMorning;2/27/2012, Vol. 20 Issue 9, p1 

    The article reports on the increase in the earnings of the Medtronic Inc. in the third quarter of 2011 and also informs about the low sales of the implantable heart devices and spinal products in the U.S. As stated, the company's profit increased by one percent during the period which ended on...

  • Abbott Profit Surges 47% as Drugs, Devices Fuel Sales.  // MondayMorning;1/26/2009, Vol. 17 Issue 3, p1 

    The article reports on the 28% increase of quarterly earnings at Abbott Laboratories Inc. in the U.S. in 2008. More specifically, sales for its drugs, nutritional products and medical devices, including its new Xience stent used to prop open coronary arteries. It mentions that the strong sales...

  • St. Jude falls on soft earnings. Investor's Business Daily // Investors Business Daily;4/17/2014, pA02 

    Device maker St.

  • Looking at value. Hasenfuss, Marc // Finance Week;Oct2002 Supplement, p39 

    Focuses on the significance of the earnings per share in the determining the financial performance of various firms in South Africa. Level of profitability; Availability of funds; Assessment on the revenue growth of the firms.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics